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Aim: To establish whether associations between total, prolonged and breaks in sedentary time and 
cardio-metabolic health differ when assessed by thigh-worn (activPAL) and waist-worn 
accelerometry (ActiGraph). 
Methods: This study reports data from three studies which recruited participants at a high risk of 
type 2 diabetes from the East Midlands area, United Kingdom (2010-2014) and assessed sedentary 
behaviour using two devices: activPAL worn on the thigh continuously and ActiGraph worn on the 
waist during waking hours. Average total, prolonged (bouts lasting ≥30minutes) and breaks in 
sedentary time were calculated. Cardiometabolic health markers included adiposity, total, LDL and 
HDL cholesterol, triglycerides, blood pressure and glucose (fasting, 2hr and HbA1c). Clustered 
cardiometabolic risk was calculated. Linear regression analysis examined the associations with 
cardio-metabolic health, adjusted for basic confounders. 
Results: 1457 participants (mean age: 59.38 ± 11.85; 51.7% male; mean BMI: 30.19 ± 5.59 kg/m2) 
with at least four valid days of both activPAL and ActiGraph data were included. ActivPAL and 
ActiGraph sedentary variables were moderately correlated (.416  - .648, p<0.01), however all 
variables, except average sedentary time (activPAL: 9.13  ± 1.85 hrs/day vs ActiGraph: 9.22 ± 1.58, 
p=0.063), were significantly different from each other (p>0.05). For total and prolonged sedentary 
time there was consistency in the direction and magnitude of associations for adiposity, HDL, 
triglycerides and cardiometabolic risk across both devices and for breaks in sedentary time with 
adiposity and cardiometabolic risk. Differences were observed across devices for diastolic blood 
pressure for total and prolonged sedentary time, 2hr glucose for total sedentary time and HDL for 
breaks in sedentary time. No other associations were observed for any other health markers for 
either device. 
Conclusions: Our results suggest that associations with cardiometabolic health are largely 
comparable across the two common assessments of sedentary behaviour but researchers should be 






























A wealth of epidemiological evidence now exists linking high levels of sedentary behaviour, defined 
as sitting, lying and reclining behaviours with low energy expenditure performed during waking 
hours, to morbidity (Wilmot, Biswas, Patterson) and mortality (Patterson et al 2018; Ku et al 2018). 
However, sedentary behaviour has mainly been assessed by self-report, surrogate measures of 
sitting (e.g., TV viewing), and waist-worn accelerometry. The latter infers sedentary behaviour from 
lack of movement rather than assessing the specific posture of sitting. Some studies (Healy et al 
2008; Healy et al 2011; Henson et al 2013), but not all (Cooper et al 2012; Jefferis et al 2018), also 
suggest that the number of breaks in sedentary behaviour per day is an important factor for some 
aspects of health. These ‘interruptions in sitting’ have however been inferred from waist-worn 
accelerometer data in epidemiology research. Using data from waist-worn accelerometers, 
researchers commonly use a cut-off of <100 counts/minute to define sedentary time, which may 
overestimate time spent sedentary due to upright activity (e.g., standing) with limited movement 
being included within this threshold. Furthermore, a break in sedentary behaviour is determined 
when an individual moves above the 100 count/minute threshold, consequently changes from 
standing to ambulation may be classified as a ‘break’ leading to an overestimation in the number of 
breaks per day.  
 
These issues with sedentary behaviour measurement were recently highlighted as a major limitation 
with the current epidemiology evidence base (Stamatakis et al 2018). A major step forward in this 
research area would be to measure sedentary time and breaks in sedentary time as accurately as 
possible by directly assessing the posture of sitting. One such device that can measure sitting is the 
activPAL accelerometer worn on the thigh. This device can accurately record time spent sitting/lying, 
standing and stepping as well as transitions from a seated to upright posture (Edwardson et al 2016). 
In order to aid the interpretation of previous epidemiological research and advance our 
understanding of sedentary behaviour as a risk factor for health, it is imperative we understand 
whether, despite not directly measuring sitting and breaks in sitting, the use of cut-points to 
determine sedentary behaviour from waist-worn accelerometer data produce similar associations 
with health as a direct assessment of posture, such as data collected from a thigh worn 
accelerometer. Indeed, research has shown when the activPAL and the waist-worn ActiGraph 
devices are worn simultaneously there can be a 2-hr difference in sedentary time between the two 
monitors (Koster et al 2016), accordingly this could potentially influence associations with health. To 
our knowledge no studies have been published directly comparing activPAL and ActIgraph measured 
sedentary behaviours and associations with health. 
 
Therefore, the aim of this study was to establish whether associations between total, prolonged and 
breaks in sedentary time and cardio-metabolic health differ when sedentary behaviours are assessed 




Design and participants 
This study used combined data from three diabetes prevention studies: Project STAND (Wilmot et al; 
Biddle et al), Walking Away from Diabetes (Yates et al; Yates et al 2017), and PROPELS (Yates et al); 
all of which has been described in detail elsewhere. Baseline data for Project STAND and PROPELS 
were used and collected in 2010 and 2013-2014 respectively. Data collected at 36 month follow up, 
during 2013-2014, were used for Walking Away, as this was the only time point where the activPAL 
was included. All studies recruited participants that were deemed to be at a high risk of developing 
type 2 diabetes (T2DM) although the method of identification and the inclusion criteria varied 




Project STAND: Adults aged 18-40 years of age were recruited from General Practices (GP) within 
Leicestershire and Northamptonshire, central England, UK. GP databases were searched for 
individuals within our target age range and had a BMI in the obese range (≥30kg/m2 with 
≥27.5kg/m2 for South Asians) or overweight range (≥25kg/m2 with ≥23kg/m2 for South Asians) and 
with one or more additional risk factor for diabetes i) family history of diabetes or cardiovascular 
disease in a first degree relative; ii) previous gestational diabetes; iii) polycystic ovarian syndrome; 
iv) HbA1c ≥5.8%; v). impaired glucose tolerance and/or impaired fasting glucose. The study was 
approved by the Nottingham National Health Service (NHS) Research Ethics Committee. 
 
Walking Away from Diabetes: Adults aged 30-75 years of age were recruited from General Practices 
(GP) within Leicestershire, UK. A modified version of the automated Leicester Risk Score (Gray et al) 
was used on GP databases to rank individuals for diabetes risk using predefined weighted variables 
(age, gender, ethnicity, body mass index (BMI), family history of T2DM and use of antihypertensive 
medication). Individuals scoring in the 90th percentile within each GP were invited. The study was 
approved by the Nottingham National Health Service (NHS) Research Ethics Committee. 
 
PROPELS: Adults aged 40–74 years of age for white European, or aged 25–74 years of age for South 
Asian were recruited from GP practices within Leicestershire and Cambridge, UK. In Cambridge 
existing research databases were also used to identify eligible individuals. Databases, both GP and 
existing, were searched for individuals within our target age range for ethnicity and who had a 
previous blood glucose or HbA1c result recorded in the prediabetes range (NICE, 2012) within the 
last 5 years. The study was approved by the NHS East Midlands Committee. 
 
Individuals who met the inclusion criteria for the studies were sent a letter from the general 
practitioner or the Principal Investigator (for existing databases) inviting them to take part along 
with study information and a reply slip. Reply slips were returned directly to the research team and 
interested individuals were contacted and booked for their measurement visit. Written informed 
consent was taken at the baseline assessment.  
 
Demographics and Anthropometric measures 
A healthcare professional obtained information on age, sex, ethnicity, smoking status, medical 
history and medication via a short interview. Height (Leicester Height Measure), body weight 
(Tanita, West Drayton, UK), body fat (Tanita, West Drayton, UK) and waist circumference (midpoint 
between the lower costal margin and iliac crest) were measured to the nearest 0.5cm, 0.1 kg, 0.1%, 
and 0.5 cm, respectively. Body mass index was calculated as by the Tanita scales as kg/m2. 
 
Objectively measured sedentary behaviour and physical activity 
activPAL: Participants were asked to wear the activPAL (PAL Technologies, Glasgow, UK) for 10 days 
in Project STAND and 7 days in Walking Away from Diabetes and PROPELS. In all three studies the 
activPAL was worn 24hr/day and was fully waterproofed using nitrile sleeves and Hypafix and 
attached to the thigh using Hypafix dressing. Devices were initialised using the default settings. Data 
were processed in STATA using a validated automated algorithm (Winkler et al). This algorithm 
separates waking wear data from everything else i.e., time in bed, prolonged non-wear and invalid 
data. Heatmaps of processed data were created (Edwardson et al) to visually check the processed 
data and any occasions where the algorithm appeared to incorrectly code data, sleep/wear diaries 
were checked against the heat maps and data were corrected if necessary. Data were considered 
valid if a day consisted of ≥10 hours of waking wear data, >500 steps and <95% spent in any one 
behaviour (e.g., sitting, standing, or stepping) (Winkler et al). Participants were required to have at 
least four valid days to be included in this analysis. Automated code in STATA was then used on the 




ActIgraph: Participants were asked to wear the ActiGraph accelerometer (ActiGraph, Pensacola, FL, 
USA) for 10 days in Project STAND and 7 days in Walking Away from Diabetes and PROPELS. In all 
three studies the ActiGraph was worn on an elastic belt on the right midaxillary line of the hip during 
waking hours only and removed for any water-based activities. Devices were initialised with a 
sampling frequency of 5 seconds, 15 seconds and 100Hz in Project STAND, Walking Away and 
PROPELS respectively and then all data was reintegrated into 60 second epochs. Data were 
processed using a commercially available package (KineSoft version 3.3.76, Loughborough, UK). Non-
wear periods, defined as ≥60 minutes of consecutive zero counts with no allowance for counts 
greater than zero (Orme et al 2014), were removed from the data, days with ≥10 hours of wear data 
were considered valid (Matthews et al 2012) and participants with at least four valid days were 
included in the analysis. Sedentary behaviour was determined using a threshold of <100 counts/min, 
and moderate to vigorous physical activity was derived using a threshold of ≥1952 counts/min 
(Freedson et al 1998). 
 
Metabolic and cardiovascular markers 
Arterial blood pressure was measured in the sitting position (Omron Healthcare, Henfield, UK); three 
measurements were obtained and the average of the last two measurements was used. HDL, LDL, 
total cholesterol, triglycerides, and HbA1c were measured in all three studies and in Project STAND 
and Walking Away fasting and 2-hour challenge glucose were also measured using an Oral Glucose 
Tolerance Test (OGTT). For Project STAND and Walking Away participants were asked to fast 
overnight. Cholesterol and triglycerides were measured using standard enzymatic techniques, 
glucose samples using a glucose oxidase method and HbA1c using the Bio-Rad Variant II HPLC 
system (Bio-Rad Clinical Diagnostics, Hemel Hempstead, UK). Analysis was conducted by individuals 
blinded to the patients’ identity, using stable methodology standardised to external quality 
assurance reference values. 
 
Statistical analysis 
Statistical analyses were performed using IBM SPSS Statistics 24. 
 
Correlation coefficients and paired t-tests were used to assess the strength of the relationship and 
the differences, respectively between the following: activPAL waking wear time and ActiGraph wear 
time, activPAL assessed sitting time and ActiGraph assessed sedentary time, activPAL assessed 
prolonged sitting time and ActiGraph assessed prolonged sedentary time and activPAL assessed sit-
to-upright transitions and ActiGraph breaks in sedentary time.  
 
HDL cholesterol and triglycerides were log transformed due to their skewed distribution. A clustered 
cardiometabolic risk score was generated using the following health markers: waist circumference, 
HDL cholesterol, triglycerides, systolic and diastolic blood pressure and HbA1c. For the risk score, 
each variable was log transformed, followed by conversion to z-scores, HDL z score was inverted, 
blood pressure variables were summed and averaged and finally all z score variables were summed 
and divided by the number of variables included (n=5). Linear regression was used to examine 
associations of total sedentary time, prolonged sedentary and breaks in sedentary time, measured 
by the ActiGraph and activPAL, with cardiometabolic health markers (adiposity, blood pressure, 
fasting and 2hour glucose, HbA1c, total cholesterol, HDL and LDL and triglycerides) and the 
cardiometabolic risk score. The model was adjusted for age (continuous), sex (male, female), 
ethnicity (white, non-white), smoking status (never and previous, current), family history of T2DM 
(yes, no), β-blocker (yes, no) and lipid lowering medication status (yes, no), activPAL/ActiGraph 
waking wear time. Given some dependent variables were log-transformed and to allow for direct 
comparison between measures and outcomes, results are reported as standardized regression 





Out of the 2278 participants across the three studies, a total of 1457 (64%) participants (mean age: 
59.38 ± 11.85; 51.7% male; mean BMI: 30.19 ± 5.59 kg/m2) provided at least four days of valid 
activPAL and ActiGraph data and were included in this analysis. Participant characteristics of those 
included are displayed in Table 1.  There were no differences in participant characteristics between 
those who provided valid data and those who did not, with the exception of weight where those 
included weighed slightly less than those who were not included (84.64 ± 18.23 vs 86.65 ± 19.24 kgs, 
p=.026). 
 
Time spent in different behaviours (sedentary time, prolonged sedentary time and breaks in 
sedentary time) measured by the activPAL and ActiGraph are presented in Table 2. ActivPAL and 
ActiGraph sedentary variables were moderately correlated (.416  - .648, p<0.01), however all 
variables, except average sedentary time (activPAL: 9.13  ± 1.85 hrs/day vs ActiGraph: 9.22 ± 1.58, 
p=0.063), were different from each other (p<0.05). 
 
Figures 1-3 present the associations between activPAL and ActiGraph assessed sedentary behaviour 
variables and cardiometabolic health. After adjustment for basic confounders, associations of both 
activPAL and ActiGraph assessed total and prolonged sedentary time with BMI, waist circumference, 
HDL, triglycerides and cardiometabolic risk were in the same direction (negative association for HDL 
and positive for all other markers) and of similar magnitude. Additional associations were observed 
for activPAL assessed total and prolonged sedentary time and diastolic blood pressure and ActiGraph 
assessed total sedentary time and 2 hr glucose. Associations between activPAL and ActiGraph 
assessed breaks in sedentary time with BMI, waist circumference and cardiometabolic risk were in 
the same direction and of similar magnitude, with additional associations seen for activPAL assessed 




Despite a growth in studies using device-based assessments of sedentary behaviour to examine 
associations with health, the interpretation of these is still limited by the estimation of sedentary 
behaviour through lack of movement rather than the posture of sitting. We wanted to examine, in a 
cohort of individuals with two assessments of sedentary behaviour (one through lack of movement 
and one based on posture) whether associations with cardiometabolic health were consistent across 
both measurement methods. On the whole we demonstrated broad consistency in associations 
across the two devices. More specifically, we observed that the direction and magnitude of 
associations between total, prolonged and breaks in sedentary time and cardiometabolic risk and 
adiposity markers of health were consistent across measurement method. Consistency was also 
observed for associations between total and prolonged sedentary time and HDL and triglycerides 
across measurement method. Some differences in associations for the different devices were 
observed for diastolic blood pressure for total and prolonged sedentary time, 2hr glucose for total 
sedentary time and HDL for breaks in sedentary time. No other associations were observed for any 
other health markers for either device. 
 
We have shown that results are broadly consistent across sedentary behaviour determined either by 
a waist-worn accelerometer or an accelerometer which identifies the specific posture of 
sitting/lying. However, researchers should be aware that some differences in results may exist for 
certain markers of health i.e., 2hr glucose, HDL cholesterol and triglycerides. A previous review 
(Brocklebank et al 2015) stated that results were inconclusive for an association between sedentary 
time and breaks in sedentary time, using waist-worn accelerometry, and 2 hour glucose and HDL 
cholesterol respectively, with some studies reporting positive associations and some no associations. 
 
 
In the current analyses, ActiGraph assessed sedentary time was positively associated with 2 hour 
glucose whereas activPAL assessed sedentary time was not. In contrast, activPAL assessed breaks in 
sedentary time were positively associated with HDL cholesterol whereas ActiGraph breaks were not. 
Furthermore, in this previous review, ActiGraph assessed ‘breaks’ in sedentary time were reported 
to have a negative association with triglycerides which is consistent with the present findings but 
contrasts the results observed for activPAL assessed breaks.  
Only one other large study has been published reporting associations between activPAL assessed 
sedentary accumulation patterns and cardiometabolic risk biomarkers (Bellettiere et al 2017). Our 
results (i.e., significant and non-significant associations) were consistent for nearly all sedentary 
behaviour variables and cardiometabolic markers with this previous study, with the exception of 
breaks in sitting time and HDL cholesterol and total and prolonged sitting and diastolic blood 
pressure. Further research using direct assessments of sitting behaviours are needed to confirm 
these findings. 
 
The majority of previous research has demonstrated an overestimation of daily sedentary time, 
sometimes up to 2 hours per day when assessed by the waist-worn ActiGraph using a cutpoint of 
<100 counts per minutes compared to the thigh worn activPAL (Koster et al 2016; Hart et al 2011; 
Judice et al 2015). However, findings from another recent study (Pfister et al 2017) as well as our 
present results showed little difference for average daily sedentary time. Although, similar to 
previous studies (Barreira et al 2015, Judice et al 2015) we observed a higher number of breaks in 
sedentary time per day recorded by the ActiGraph compared to the activPAL. These differences will 
be important for prevalence research but as demonstrated in the current analyses may not impact 
on associations with health. 
 
Strengths of this study include a large dataset where sedentary behaviour has been assessed using 
two commonly used accelerometers. However, the sample was considerably smaller for fasting and 
2hr glucose. Furthermore, although we restricted the analysis to only include those providing at 
least four valid days of data, different days of data may have been included for the activPAL and 
ActiGraph. Different processing methods were applied to the activPAL and ActiGraph data, which 
may have influenced the results however, these represent researcher practice and may be a better 
reflection of the literature rather than matching the data exactly. The associations should, however, 
be interpreted with caution due to the cross-sectional design of this study which limits the ability to 
make causal inferences. Finally, we only adjusted for basic confounders in order to demonstrate any 
similarities and differences in associations.  
 
In summary, associations with cardiometabolic health are largely comparable across the two 
common device-based assessments of sedentary behaviour but researchers should be aware that 
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Table 1.  Participant characteristics 
Continuous parametric results as mean±SD, number (column percentage) and continuous 
nonparametric results as median (interquartile range). 
 
Characteristics N  
Age (years) 1454 59.38  ±  11.85 
Male (%) 1455 51.7 
White European (%) 1456 75.9 
Family history of diabetes (%) 1444 43.5 
Current and past smokers (%) 1456 33.7% 
Weight (kg) 1453 84.58  ±  18.13 
Waist circumference (cm) 1449 100.36 ± 13.66  
BMI (kg/m2) 1453 30.19  ± 5.59 
Diastolic Blood Pressure (mmHg) 1454 82.00 ± 10.84 
Systolic Blood Pressure (mmHg) 1454 130.95 ± 17.56 
HDL (mmol/l) 1441 1.44 ± 0.41 
LDL (mmol/l) 1425 3.02 ± 0.91 
Total Cholesterol (mmol/l) 1451 5.14 ± 1.10 
Triglycerides (mmol/l) 1450 1.51 ± 0.89 
HbA1c (%) 1452 5.77 ± 0.39 
Fasting plasma glucose (mmol/l) 508  5.16 ± 0.74 







Table 2. Summary of the activPAL and ActiGraph output variables (n=1457) 




Variables activPAL ActiGraph Correlation Paired t-test 
Average waking wear hours/day 
(hours) 
15.71  ± 1.13 14.67  ± 1.37 .543** P<0.001 
Average sitting/lying time/day (hours) 9.13  ± 1.85   9.22 ± 1.58 .648** 
 
P=0.063 
Average prolonged bouts (≥30mins) of 
sitting/lying time/day (hours) 
4.82  ± 1.85 2.83  ± 1.49 .505** P<0.001 
Average number of breaks in 
sitting/day 
48.03  ± 
15.13 
85.95  ± 
16.99 
.416** P<0.001 
Average standing/day (hours) 4.79  ± 1.59 N/A N/A N/A 
Average stepping/day (hours) 1.79  ± 0.66 N/A N/A N/A 






Figure 1. Associations between activPAL daily sitting time and ActiGraph daily sedentary time and 
cardio-metabolic health. Adjusted for age, sex, ethnicity, smoking status, family history of T2DM, β-





Figure 2. Associations between activPAL daily prolonged sitting time and ActiGraph daily 
prolonged sedentary time and cardio-metabolic health. Adjusted for age, sex, ethnicity, smoking 






Figure 3. Associations between activPAL breaks in sitting time and ActiGraph breaks in sedentary 
time and cardio-metabolic health. Adjusted for age, sex, ethnicity, smoking status, family history of 
T2DM, β-blocker and lipid lowering medication status, activPAL/ActiGraph wear time. 
 
